Clinical Trials Directory

Trials / Completed

CompletedNCT00929461

Impact of Omega-3 Fatty Acids on Lactate

Do Omega-3 Fatty Acids Have Any Impact On Serum Lactate Levels After Major Gastric Cancer Surgery?

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
Sponsor
Ege University · Academic / Other
Sex
All
Age
25 Years – 65 Years
Healthy volunteers

Summary

Pre- and intra-operative nutritional support in patient undergoing major surgery results in decreased morbidity and mortality. Studies investigating the role of omega-3 fatty acids in these patients are increasing. Some are focused on perfusion at the cellular level. This study was undertaken to address the effect of postoperative administration of omega-3 fatty acids on cellular hypoperfusion associated with major gastric surgery.

Conditions

Interventions

TypeNameDescription
DRUGLipovenoes® 10% and Omegaven®,All patients received TPN for 5 days postoperatively, according to a standard protocol: 3 g/kg BW glucose (5% Dextrose in Ringer's Lactate, Biosel, Istanbul), 1.2 g/kg BW amino acids (Aminosteril 10%, Fresenius-Kabi) and 0.8 g/kg BW omega-6 fatty acids (Lipovenoes® 10%, Fresenius-Kabi) were provided to both groups through an indwelling central venous catheter. In the omega-3 group, the lipid content of TPN was replaced partially by omega-3 fatty acids (Omegaven®, Fresenius-Kabi) up to 0.2 g/kg BW per day.

Timeline

First posted
2009-06-29
Last updated
2009-11-25

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT00929461. Inclusion in this directory is not an endorsement.